- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Randomised controlled trial, Single centre
- Objective: To investigate the bioequivalence of two formulations of Aterixen 100 mg tablets, aiming to determine if they consistently deliver the same amount of drug into the body
- Number of participants enrolled: Enrollment data not available
- Study enrolling from to
- Study includes follow-up for 14 days
Study Data
- Adults (18-64 years)
- General population
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Aterixen
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to